HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ewa Laszuk Selected Research

DOTA-NHS

10/2020Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ewa Laszuk Research Topics

Disease

1Neoplasms (Cancer)
10/2020
1Lymphoma (Lymphomas)
10/2020
1Infections
01/2017
1Inflammation (Inflammations)
01/2017
1Insulinoma
01/2016

Drug/Important Bio-Agent (IBA)

11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2020
1DOTA-NHSIBA
10/2020
1177Lu-DOTA-rituximabIBA
10/2020
1Chelating AgentsIBA
10/2020
1RadiopharmaceuticalsIBA
01/2017
1exametazimeFDA Link
01/2017
1Technetium (Technetium 99m)IBA
01/2017
1EDDA (NiEDDA)IBA
01/2016
1Exenatide (Byetta)FDA Link
01/2016

Therapy/Procedure

1Radioimmunotherapy
10/2020